FDA's Letter to Heron Therapeutics (HRTX) Over Sustol Approval
Get Alerts HRTX Hot Sheet
Join SI Premium – FREE
Below is the FDA's approval letter Heron Therapeutics' (Nasdaq: HRTX) SUSTOL:
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CapitalOne Starts Heron Therapeutics (HRTX) at Overweight
- Alvotech (ALVO) Reports Topline Results from a Confirmatory Clinical Study for AVT05
- ASLAN Pharmaceuticals (ASLN) Announces Late Breaking Abstract on Eblasakimab in COPD Accepted for Presentation at the American Thoracic Society International Conference
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!